LUIS MIGUEL RUILOPE URIOSTE-rekin lankidetzan egindako argitalpenak (28)

2023

  1. Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors

    Biomedicine and Pharmacotherapy, Vol. 168

  2. Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  3. Prevention of cardiorenal damage: importance of albuminuria

    European heart journal, Vol. 44, Núm. 13, pp. 1112-1123

2022

  1. Evidence of chronic kidney injury in patients not meeting KDIGO criteria for chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 7, pp. 1217-1220

  2. IMBALANCE IN BONE MORPHOGENIC PROTEINS 2 AND 7 IS ASSOCIATED WITH HYPERTENSION AND ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE

    Journal of hypertension, Vol. 40, pp. e81

  3. Prediction of the early response to spironolactone in resistant hypertension by the combination of matrix metalloproteinase-9 activity and arterial stiffness parameters

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 8, Núm. 1, pp. 68-76

2021

  1. Analysis of Global Oxidative Status Using Multimarker Scores Reveals a Specific Association Between Renal Dysfunction and Diuretic Therapy in Older Adults

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 76, Núm. 7, pp. 1198-1205

  2. Cardiovascular Risk Stratification Based on Oxidative Stress for Early Detection of Pathology

    Antioxidants and Redox Signaling, Vol. 35, Núm. 8, pp. 602-617

  3. Early renal and vascular damage within the normoalbuminuria condition

    Journal of hypertension, Vol. 39, Núm. 11, pp. 2220-2231

  4. Lifestyle interventions for the prevention and treatment of hypertension

    Nature Reviews Cardiology, Vol. 18, Núm. 4, pp. 251-275

  5. Tca cycle and fatty acids oxidation reflect early cardiorenal damage in normoalbuminuric subjects with controlled hypertension

    Antioxidants, Vol. 10, Núm. 7

2020

  1. Differential metabolic profile associated with the condition of normoalbuminuria in the hypertensive population

    Nefrologia, Vol. 40, Núm. 4, pp. 439-445

  2. Novel molecular plasma signatures on cardiovascular disease can stratify patients throughout life

    Journal of Proteomics, Vol. 222

  3. Oxidized low-density lipoprotein associates with ventricular stress in young adults and triggers intracellular ca2+ alterations in adult ventricular cardiomyocytes

    Antioxidants, Vol. 9, Núm. 12, pp. 1-15

  4. Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations

    Journal of Molecular Medicine, Vol. 98, Núm. 11, pp. 1603-1613

2019

  1. Association between renal dysfunction and metalloproteinase (MMP)-9 activity in hypertensive patients

    Nefrologia, Vol. 39, Núm. 2, pp. 184-191

  2. Lifetime cardiovascular risk is associated with a multimarker score of systemic oxidative status in young adults independently of traditional risk factors

    Translational Research, Vol. 212, pp. 54-66

2018

  1. Translational science in albuminuria: A new view of de novo albuminuria under chronic RAS suppression

    Clinical Science, Vol. 132, Núm. 7, pp. 739-758

2017

  1. Citric Acid Metabolism in Resistant Hypertension: Underlying Mechanisms and Metabolic Prediction of Treatment Response

    Hypertension, Vol. 70, Núm. 5, pp. 1049-1056

  2. Proteomic analysis of blood extracellular vesicles in cardiovascular disease by LC-MS/MS analysis

    Methods in Molecular Biology (Humana Press Inc.), pp. 141-149